Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2009 1
2010 3
2011 1
2012 5
2015 4
2016 3
2017 7
2018 7
2019 6
2020 11
2021 14
2022 7
2023 2
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

62 results

Results by year

Filters applied: . Clear all
Page 1
Sarcoma Tumor Microenvironment.
Tsagozis P, Gonzalez-Molina J, Georgoudaki AM, Lehti K, Carlson J, Lundqvist A, Haglund F, Ehnman M. Tsagozis P, et al. Among authors: haglund f. Adv Exp Med Biol. 2020;1296:319-348. doi: 10.1007/978-3-030-59038-3_20. Adv Exp Med Biol. 2020. PMID: 34185302
Renal cell carcinoma escapes NK cell-mediated immune surveillance through the downregulation of DNAM-1.
Tong L, Kremer V, Neo SY, Liu Y, Chen Y, Wagner AK, Yang Y, Chen Z, Seitz C, Tobin NP, Ligtenberg MA, Alici E, Chen X, Haglund F, Seliger B, Harmenberg U, Colón E, Plogell AS, Liu LL, Lundqvist A. Tong L, et al. Among authors: haglund f. Cancer Commun (Lond). 2023 Jul;43(7):855-859. doi: 10.1002/cac2.12446. Epub 2023 Jun 14. Cancer Commun (Lond). 2023. PMID: 37314951 Free PMC article. No abstract available.
Tumor-associated NK cells drive MDSC-mediated tumor immune tolerance through the IL-6/STAT3 axis.
Neo SY, Tong L, Chong J, Liu Y, Jing X, Oliveira MMS, Chen Y, Chen Z, Lee K, Burduli N, Chen X, Gao J, Ma R, Lim JP, Huo J, Xu S, Alici E, Wickström SL, Haglund F, Hartman J, Wagner AK, Cao Y, Kiessling R, Lam KP, Westerberg LS, Lundqvist A. Neo SY, et al. Among authors: haglund f. Sci Transl Med. 2024 May 15;16(747):eadi2952. doi: 10.1126/scitranslmed.adi2952. Epub 2024 May 15. Sci Transl Med. 2024. PMID: 38748775
Inflammatory infiltrates in parathyroid tumors.
Haglund F, Hallström BM, Nilsson IL, Höög A, Juhlin CC, Larsson C. Haglund F, et al. Eur J Endocrinol. 2017 Dec;177(6):445-453. doi: 10.1530/EJE-17-0277. Epub 2017 Aug 30. Eur J Endocrinol. 2017. PMID: 28855268 Free PMC article.
[Molecular pathology - the key to precision oncology].
Edsjö A, Palmqvist R, Haglund F, Helenius G, Lindqvist O, Fagman H, Botling J. Edsjö A, et al. Among authors: haglund f. Lakartidningen. 2021 May 10;118:20209. Lakartidningen. 2021. PMID: 33973224 Free article. Swedish.
Absence of KMT2D/MLL2 mutations in abdominal paraganglioma.
Stenman A, Juhlin CC, Haglund F, Brown TC, Clark VE, Svahn F, Bilguvar K, Goh G, Korah R, Lifton RP, Carling T. Stenman A, et al. Among authors: haglund f. Clin Endocrinol (Oxf). 2016 Apr;84(4):632-4. doi: 10.1111/cen.12884. Epub 2015 Sep 22. Clin Endocrinol (Oxf). 2016. PMID: 26303934 No abstract available.
A2B adenosine receptor antagonists rescue lymphocyte activity in adenosine-producing patient-derived cancer models.
Tay AHM, Prieto-Díaz R, Neo S, Tong L, Chen X, Carannante V, Önfelt B, Hartman J, Haglund F, Majellaro M, Azuaje J, Garcia-Mera X, Brea JM, Loza MI, Jespers W, Gutierrez-de-Teran H, Sotelo E, Lundqvist A. Tay AHM, et al. Among authors: haglund f. J Immunother Cancer. 2022 May;10(5):e004592. doi: 10.1136/jitc-2022-004592. J Immunother Cancer. 2022. PMID: 35580926 Free PMC article.
Overexpression of cytochrome P450 2A6 in adrenocortical carcinoma.
Murtha TD, Brown TC, Rubinstein JC, Haglund F, Juhlin CC, Larsson C, Korah R, Carling T. Murtha TD, et al. Among authors: haglund f. Surgery. 2017 Jun;161(6):1667-1674. doi: 10.1016/j.surg.2016.11.036. Epub 2017 Jan 7. Surgery. 2017. PMID: 28073588 Free PMC article.
62 results